Du L - Search Results

1

Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction.

Cao W, Dong C, Kim S, Hou D, Tai W, Du L, Im W, Zhang XF. Cao W, et al. Among authors: du l. Biophys J. 2021 Mar 16;120(6):1011-1019. doi: 10.1016/j.bpj.2021.02.007. Epub 2021 Feb 17. Biophys J. 2021. PMID: 33607086 Free PMC article.

2

Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS-CoV vaccine.

He Y, Li J, Du L, Yan X, Hu G, Zhou Y, Jiang S. He Y, et al. Among authors: du l. Vaccine. 2006 Jun 29;24(26):5498-508. doi: 10.1016/j.vaccine.2006.04.054. Epub 2006 May 11. Vaccine. 2006. PMID: 16725238 Free PMC article.

3

The spike protein of SARS-CoV--a target for vaccine and therapeutic development.

Du L, He Y, Zhou Y, Liu S, Zheng BJ, Jiang S. Du L, et al. Nat Rev Microbiol. 2009 Mar;7(3):226-36. doi: 10.1038/nrmicro2090. Epub 2009 Feb 9. Nat Rev Microbiol. 2009. PMID: 19198616 Free PMC article. Review.

4

Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells.

Du L, Zhao G, Li L, He Y, Zhou Y, Zheng BJ, Jiang S. Du L, et al. Biochem Biophys Res Commun. 2009 Jul 10;384(4):486-90. doi: 10.1016/j.bbrc.2009.05.003. Epub 2009 May 5. Biochem Biophys Res Commun. 2009. PMID: 19422787 Free PMC article.

5

A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity.

Du L, Zhao G, Chan CC, Li L, He Y, Zhou Y, Zheng BJ, Jiang S. Du L, et al. Viral Immunol. 2010 Apr;23(2):211-9. doi: 10.1089/vim.2009.0090. Viral Immunol. 2010. PMID: 20374001 Free PMC article.

6

Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies.

Du L, Zhao G, Zhang X, Liu Z, Yu H, Zheng BJ, Zhou Y, Jiang S. Du L, et al. Biochem Biophys Res Commun. 2010 Jul 2;397(3):580-5. doi: 10.1016/j.bbrc.2010.05.161. Biochem Biophys Res Commun. 2010. PMID: 20617558 Free PMC article.

7

Protocol for recombinant RBD-based SARS vaccines: protein preparation, animal vaccination and neutralization detection.

Du L, Zhang X, Liu J, Jiang S. Du L, et al. J Vis Exp. 2011 May 2;(51):2444. doi: 10.3791/2444. J Vis Exp. 2011. PMID: 21587153 Free PMC article.

8

A critical HA1 neutralizing domain of H5N1 influenza in an optimal conformation induces strong cross-protection.

Du L, Zhao G, Sun S, Zhang X, Zhou X, Guo Y, Li Y, Zhou Y, Jiang S. Du L, et al. PLoS One. 2013;8(1):e53568. doi: 10.1371/journal.pone.0053568. Epub 2013 Jan 8. PLoS One. 2013. PMID: 23320093 Free PMC article.

9

Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development.

Du L, Zhao G, Kou Z, Ma C, Sun S, Poon VK, Lu L, Wang L, Debnath AK, Zheng BJ, Zhou Y, Jiang S. Du L, et al. J Virol. 2013 Sep;87(17):9939-42. doi: 10.1128/JVI.01048-13. Epub 2013 Jul 3. J Virol. 2013. PMID: 23824801 Free PMC article.

10

A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines.

Du L, Kou Z, Ma C, Tao X, Wang L, Zhao G, Chen Y, Yu F, Tseng CT, Zhou Y, Jiang S. Du L, et al. PLoS One. 2013 Dec 4;8(12):e81587. doi: 10.1371/journal.pone.0081587. eCollection 2013. PLoS One. 2013. PMID: 24324708 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,174 results

Search Page

Filters